-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
LASV inhibitor 3.3
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/554438-52-72d.gif)
| Category | Arenavirus |
| CAS | 554438-52-7 |
| Description | LASV inhibitor 3.3 is a specific inhibitor of Lassa fever virus (LASV) that inhibits LASV GP-mediated infection and cross-links to the LASV receptor, LAMP1, in cells. |
Product Information
| Synonyms | LASV inhibitor 3.3;554438-52-7;N-(2-(4-benzhydrylpiperazin-1-yl)-2-oxoethyl)adamantane-1-carboxamide;N-[2-(4-benzhydrylpiperazin-1-yl)-2-oxoethyl]adamantane-1-carboxamide;LASV-IN-3.3;LASV inhibitor 3.3?;SCHEMBL14705613;SCHEMBL14705624;GLXC-15920;EX-A8202;AKOS040760019;MS-28729;HY-124871;CS-0088737;Z31482169; |
| IUPAC Name | N-[2-(4-benzhydrylpiperazin-1-yl)-2-oxoethyl]adamantane-1-carboxamide |
| Molecular Weight | 394.3 |
| Molecular Formula | C19H16BrN5 |
| Canonical SMILES | CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)Br |
| InChI | InChI=1S/C30H37N3O2/c34-27(21-31-29(35)30-18-22-15-23(19-30)17-24(16-22)20-30)32-11-13-33(14-12-32)28(25-7-3-1-4-8-25)26-9-5-2-6-10-26/h1-10,22-24,28H,11-21H2,(H,31,35) |
| InChIKey | CUSOKWBOIRFXDP-UHFFFAOYSA-N |
| Purity | >98% |
| Solubility | Soluble in DMSO. |
| Appearance | Solid |
| Storage | Store at -20°C |
